| [1] Morton CC. Genetics, genomics and gene discovery in the auditory system. Hum Mol Genet, 2002, 11(10): 1229-1240.[2] 管敏鑫, 赵立东. 与氨基糖甙类抗生素耳毒性相关的线粒体12S rRNA突变的流行病学特征. 中华耳科学杂志, 2006, 4(2): 98-105.[3] Guan MX. Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion, 2011, 11(2): 237-245.[4] Xing G, Chen Z, Cao X. Mitochondrial rRNA and tRNA and hearing function. Cell Res, 2007, 17(3): 227-239.[5] Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Pharmacogenomics, 2005, 6(1): 27-36.[6] 杨爱芬, 郑静, 吕建新, 管敏鑫. 修饰因子对线粒体DNA突变致聋的影响. 中华医学遗传学杂志, 2010, 28(2): 165-171.[7] Hutchin T, Haworth I, Higashi K, Fischel-Ghodsian N, Stoneking M, Saha N, Arnos C, Cortopassi G. A molecular basis for human hypersensitivity of aminoglyscoside antibiotics. Nuclear Acids Res, 1993, 21(18): 4174-4179.[8] Prezant TR, Agapian JV, Bohlman MC, Bu XD, Öztas S, Qiu WQ, Arnos KS, Cortopassi GA, Jaber L, Rotter JI, Shohat M, Fischel-Ghodsian N. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet, 1993, 4: 289-294.[9] Estivill X, Govea N, Barceló E, Badenas C, Romero E, Moral L, Scozzari R, D’Urbano L, Zeviani M, Torroni A. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet, 1998, 62(1): 27-35.[10] Matthijs G, Claes S, Longo-Bbenza B, Cassiman JJ. Non- syndromic deafness associated with a mutation and a polymorphism in the mitochondrial 12S ribosomal RNA gene in a large Zairean pedigree. Eur J Hum Genet, 1996, 4(1): 46-51.[11] Lévêque M, Marlin S, Jonard L, Procaccio V, Reynier P, Amati-Bonneau P, Baulande S, Pierron D, Lacombe D, Duriez F, Francannet C, Mom T, Journel H, Catros H, Drouin-Garraud V, Obstoy MF, Dollfus H, Eliot MM, Faivre L, Duvillard C, Couderc R, Garabedian EN, Petit C, Feldmann D, Denoyelle F. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochon-drial DNA chip. Eur J Hum Genet, 2007, 15(11): 1145-1155.[12] 张婷, 陈波蓓, 郑静, 龚莎莎, 张初琴, 吕建新, 管敏鑫. 五个母系遗传非综合征性耳聋和药物性耳聋的中国汉族家系. 中华医学遗传学, 2011, 28(4): 367-373.[13] Chen BB, Sun DM, Yang L, Zhang CQ, Yang AF, Zhu Y, Zhao JY, Chen YY, Guan MQ, Wang XJ, Li RH, Tang XW, Wang JD, Tao ZH, Lu JX, Guan MX. Mitochondrial ND5 T12338C, tRNACys T5802C, and tRNAThr G15927A variants may have a modifying role in the phe-notypic manifestation of deafness-associated 12S rRNA A1555G mutation in three Han Chinese pedigrees. Am J Med Genet, 2008, 146A(10): 1248-1258.[14] Lu JX, Qian YP, Li ZY, Yang AF, Zhu Y, Li RH, Yang L, Tang XW, Chen BB, Ding Y, Li YY, You JY, Zheng J, Tao ZH, Zhao FX, Wang JD, Sun DM, Zhao JY, Meng YZ, Guan MX. Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A > G mutation. Mitochondrion, 2010, 10(1): 69-81.[15] Zhao H, Li RH, Wang QJ, Yan QF, Deng JH, Han DY, Bai YD, Young WY, Guan MX. Maternally inherited amino-glycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet, 2004, 74(1): 139-152.[16] Rodriguez-Ballesteros M, Olarte M, Aguirre LA, Galán F, Galán R, Vallejo LA, Navas C, Villamar M, Mo-reno-Pelayo MA, Moreno F, del Castillo I. Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C→T mutation in the mitochondrial 12S rRNA gene. J Med Genet, 2006, 43(11): e54.[17] Chen J, Yang L, Yang A, Zhu Y, Zhao J, Sun D, Tao Z, Tang X, Wang J, Wang X, Tsushima A, Lan J, Li W, Wu F, Yuan Q, Ji J, Feng J, Wu C, Liao Z, Li Z, Greinwald JH, Lu J, Guan MX. Maternally inherited aminoglyco-side-induced and nonsyndromic hearing loss is associated with the 12S rRNA C1494T mutation in three Han Chi-nese pedigrees. Gene, 2007, 401(1-2): 4-11.[18] Purohit P, Stern S. Interactions of a small RNA with anti-biotic and RNA ligands of the 30S subunit. Nature, 1994, 370(6491): 659-662.[19] Fourmy D, Recht MI, Puglisi JD. Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16S rRNA. J Mol Biol, 1998, 277(2): 347-362.[20] Qian YP, Guan MX. Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deaf-ness-associated mutation. Antimicrob Agents Chemother, 2009, 53(11): 4612-4618.[21] Rieder MJ, Taylor SL, Tobe VO, Nickerson DA. Auto-mating the identification of DNA variations using qual-ity-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res, 1998, 26(4): 967-973.[22] Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet, 1999, 23(2): 147.[23] Li R, Greinwald JH, Yang L, Choo DI, Wenstrup RJ, Guan MX. Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss. J Med Genet, 2004, 41(8): 615-620.[24] De Rijk P, De Wachter R. RnaViz, a program for the visualisation of RNA secondary structure. Nucleic Ac-ids Res, 1997, 25(22): 4679-4684.[25] Lu JX, Li ZY, Zhu Y, Yang AF, Li RH, Zheng J, Cai Q, Peng GH, Zheng WW, Tang XW, Chen BB, Chen JF, Liao ZS, Yang LY, Li YY, You JY, Ding Y, Yu H, Wang JD, Sun DM, Zhao JY, Xue L, Wang JY, Guan MX. Mito-chondrial 12S rRNA variants in 1642 Han Chinese pediat-ric subjects with aminoglycoside-induced and nonsyn-dromic hearing loss. Mitochondrion, 2010, 10(4): 380- 390.[26] Tessa A, Giannotti A, Tieri L, Vilarinho L, Marotta G, Santorelli FM. Maternally inherited deafness associated with a T1095C mutation in the mDNA. Eur J Hum Genet, 2002, 9(2): 147-149.[27] Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res, 2007, 35(Database issue): D823-D828.[28] Ruiz-Pesini E, Wallace DC. Evidence for adaptive selec-tion acting on the tRNA and rRNA genes of human mito-chondrial DNA. Hum Mutat, 2006, 27(11): 1072-1081.[29] Usami SI, Abe S, Akita J, Namba A, Shinkawa H, Ishii M, Iwasaki S, Hoshino T, Ito J, Doi K, Kubo T, Nakagawa T, Komiyama S, Tono T, Komune S. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet, 2000, 37(1): 38-40.[30] Li ZY, Li RH, Chen JF, Liao ZS, Zhu Y, Qian YP, Xiong SD, Heman-Ackah S, Wu JB, Choo DI, Guan MX. Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss. Hum Genet, 2005, 117(1): 9-15.[31] Malik SG, Pieter N, Sudoyo H, Kadir A, Marzuki S. Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness patients in island Southeast Asia. J Hum Genet, 2003, 48(9): 480-483.[32] Casano RAMS, Johnson DF, Bykhovskaya Y, Torricelli F, Bigozzi M, Fischel-Ghodsian N. Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol, 1999, 20(3): 151-156.[33] Jacobs HT, Hutchin TP, Käppi T, Gillies G, Minkkinen K, Walker J, Thompson K, Rovio AT, Carella M, Melchionda S, Zelante L, Gasparini P, Pyykkö I, Shah ZH, Zeviani M, Mueller RF. Mitochondrial DNA mutations in patients with postlingual, nonsyndromic hearing impairment. Eur J Hum Genet, 2005, 13(1): 26-33.[34] Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, Lynch T, Fahn S, DiMauro S. A novel mito-chondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol, 2002, 48(5): 730-736.[35] Neefs JM, Van de Peer Y, De Rijik P, Goris A, De Wachter R. Compilation of small ribosomal subunit RNA se-quences. Nucleic Acids Res, 1991, 19(Suppl): 1987-2018.[36] Bacino C, Prezant TR, Bu XD, Fournier P, Fischel-Ghod-sian N. Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness. Pharmacogenetics, 1995, 5(3): 165-172.[37] Yuan YY, You YW, Huang DL, Cui JH, Wang Y, Wang Q, Yu F, Kang DY, Yuan HJ, Han DJ, Dai P. Comprehensive molecular etiology analysis of nonsyndromic hearing im-pairment from typical areas in China. J Transl Med, 2009, 7: 79.[38] Kong QP, Bandelt HJ, Sun C, Yao YG, Salas A, Achilli A, Wang CY, Zhong L, Zhu CL, Wu SF, Torroni A, Zhang YP. Updating the East Asian mtDNA phylogeny: a pre-requisite for the identification of pathogenic mutations. Hum Mol Genet, 2006, 15(13): 2076-2086.[39] Springer MS, Douzery E. Secondary structure and patterns of evolution among mammalian mitochondrial 12S rRNA molecules. J Mol Evol, 1996, 143(4): 357-373.[40] Guan MX, Fischel-Ghodsian N, Attardi G. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum Mol Genet, 1996, 5(7): 963-971.[41] Guan MX, Fischel-Ghodsian N, Attardi G. A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet, 2000, 9(12): 1787-1793.[42] Zhao H, Young WY, Yan QF, Li RH, Cao JY, Wang QJ, Li XM, Peters JL, Han DY, Guan MX. Functional characterization of the mitochondrial 12S rRNA C1494T mutation associated with aminoglycoside-induced and non-syn-dromic hearing loss. Nucleic Acid Res, 2005, 33(3): 1132- 1139. |
